Radiant Research has joined with Synexus to form a global site network of 185 sites. This creates the world’s largest and most patient focused site network, spanning 11 countries and offering access to more than 100 million patients in key clinical development markets, operating under the Synexus name. Together we offer data driven site selection and activation that is combined with proven patient engagement expertise across the US, Europe & Africa. Synexus is the world’s largest site network, with more than 195 sites and 1,500 employees. We provide customers with access to more than 100 million patients in key clinical development markets including Europe and the United States. Synexus offers biopharmaceutical and contract research organizations (CRO) an unmatched capacity to find the right patient for the right trial at the right time. Our global scale and world-class site network delivers unparalleled capability, including data-driven site selection and activation, combined with proven patient engagement and retention expertise across the U.S., Europe and Africa.
